Drug intelligence / Profile preview

litramine

Development stage
Unknown
Lead developer
InQpharm
Administration
Oral
01

Overview

Litramine (IQP-G-002AS) is a patented natural fiber complex developed by InQpharm for weight management. [9, 10] It is derived from the prickly pear cactus (*Opuntia ficus-indica*) and enriched with soluble fibers from *Acacia sp*. [10] Litramine is classified as a medical device and acts via a physical mechanism within the gastrointestinal tract. [2] It binds to dietary fats, forming large fat-fiber complexes that are too large to be absorbed and are subsequently excreted. [10, 11] Additionally, the soluble fibers can swell in the stomach, which increases the feeling of satiety and helps reduce appetite. [8] Clinical studies have demonstrated its effectiveness and safety in promoting weight loss and, notably, in the long-term maintenance of body weight. [10] It is available over-the-counter and marketed under various brand names, including XLS Medical and I-REMOVE. [1, 3]

Brand names
XLS MedicalI-REMOVEbmiSMARTFat Release
Other names
Opuntia ficus-indica fiber complex

Beyond the preview

Go deeper on litramine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on litramine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call